Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Certification | 2 | 2017 | 47 | 0.670 |
Why?
|
| General Surgery | 2 | 2017 | 49 | 0.660 |
Why?
|
| Test Taking Skills | 1 | 2017 | 2 | 0.570 |
Why?
|
| Internship and Residency | 2 | 2017 | 196 | 0.550 |
Why?
|
| Clinical Competence | 1 | 2017 | 217 | 0.480 |
Why?
|
| Kidney Transplantation | 4 | 2021 | 120 | 0.410 |
Why?
|
| Pancreas Transplantation | 5 | 2009 | 8 | 0.390 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2022 | 23 | 0.370 |
Why?
|
| Liver Transplantation | 4 | 2014 | 93 | 0.330 |
Why?
|
| Educational Measurement | 2 | 2017 | 57 | 0.260 |
Why?
|
| Aneurysm | 1 | 2022 | 10 | 0.200 |
Why?
|
| Arteriovenous Fistula | 1 | 2022 | 12 | 0.200 |
Why?
|
| Renal Dialysis | 3 | 2022 | 115 | 0.190 |
Why?
|
| Tissue and Organ Procurement | 3 | 2009 | 24 | 0.180 |
Why?
|
| Surgical Instruments | 1 | 2020 | 18 | 0.180 |
Why?
|
| Graft Rejection | 3 | 2009 | 63 | 0.170 |
Why?
|
| Adult | 14 | 2020 | 7336 | 0.170 |
Why?
|
| Organ Transplantation | 3 | 2008 | 22 | 0.170 |
Why?
|
| Health Care Costs | 1 | 2020 | 75 | 0.170 |
Why?
|
| Suture Techniques | 1 | 2020 | 136 | 0.170 |
Why?
|
| Graft Survival | 5 | 2014 | 92 | 0.160 |
Why?
|
| Intestines | 2 | 2008 | 88 | 0.150 |
Why?
|
| Retrospective Studies | 10 | 2022 | 3220 | 0.150 |
Why?
|
| Male | 15 | 2020 | 13917 | 0.140 |
Why?
|
| Humans | 20 | 2022 | 25692 | 0.140 |
Why?
|
| Simulation Training | 1 | 2017 | 35 | 0.140 |
Why?
|
| Program Evaluation | 1 | 2017 | 124 | 0.130 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 69 | 0.130 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 119 | 0.130 |
Why?
|
| Female | 14 | 2020 | 14273 | 0.130 |
Why?
|
| Curriculum | 1 | 2017 | 136 | 0.130 |
Why?
|
| Quality Improvement | 1 | 2017 | 132 | 0.130 |
Why?
|
| Treatment Outcome | 9 | 2022 | 3231 | 0.130 |
Why?
|
| United States | 3 | 2017 | 1943 | 0.130 |
Why?
|
| Time Factors | 5 | 2022 | 1336 | 0.120 |
Why?
|
| Liver Cirrhosis | 1 | 2014 | 37 | 0.120 |
Why?
|
| Catheter Obstruction | 1 | 2013 | 2 | 0.110 |
Why?
|
| Angioplasty, Balloon | 1 | 2013 | 13 | 0.110 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2013 | 12 | 0.110 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2013 | 21 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 148 | 0.110 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 32 | 0.100 |
Why?
|
| Stents | 1 | 2013 | 80 | 0.100 |
Why?
|
| Middle Aged | 12 | 2020 | 8403 | 0.100 |
Why?
|
| Vascular Patency | 2 | 2022 | 17 | 0.100 |
Why?
|
| Liver | 2 | 2009 | 144 | 0.090 |
Why?
|
| Immunosuppressive Agents | 2 | 2009 | 124 | 0.090 |
Why?
|
| Stomach | 1 | 2009 | 15 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2009 | 24 | 0.080 |
Why?
|
| Leucine | 1 | 2009 | 10 | 0.080 |
Why?
|
| Gastric Fistula | 1 | 2009 | 5 | 0.080 |
Why?
|
| Intestinal Fistula | 1 | 2009 | 5 | 0.080 |
Why?
|
| Diabetic Nephropathies | 1 | 2009 | 20 | 0.080 |
Why?
|
| Living Donors | 1 | 2009 | 15 | 0.080 |
Why?
|
| Colonic Diseases | 1 | 2009 | 10 | 0.080 |
Why?
|
| Hypoglycemia | 1 | 2009 | 13 | 0.080 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2008 | 2 | 0.080 |
Why?
|
| Organ Preservation Solutions | 1 | 2008 | 1 | 0.080 |
Why?
|
| Pancreatectomy | 1 | 2008 | 11 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2008 | 11 | 0.080 |
Why?
|
| Colon | 1 | 2009 | 131 | 0.080 |
Why?
|
| Carcinoma, Papillary | 1 | 2008 | 19 | 0.080 |
Why?
|
| Aged | 9 | 2020 | 8501 | 0.080 |
Why?
|
| Menorrhagia | 1 | 2008 | 3 | 0.080 |
Why?
|
| Program Development | 1 | 2008 | 59 | 0.070 |
Why?
|
| Hysterectomy | 1 | 2008 | 22 | 0.070 |
Why?
|
| Cystic Fibrosis | 1 | 2007 | 10 | 0.070 |
Why?
|
| Child | 5 | 2009 | 1277 | 0.070 |
Why?
|
| Lung Transplantation | 1 | 2007 | 12 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 129 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2008 | 170 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2009 | 157 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 2 | 2002 | 89 | 0.060 |
Why?
|
| Survival Analysis | 3 | 2014 | 246 | 0.050 |
Why?
|
| Adolescent | 4 | 2009 | 2076 | 0.050 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2002 | 15 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2002 | 40 | 0.050 |
Why?
|
| Waiting Lists | 2 | 2014 | 16 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2009 | 640 | 0.050 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2022 | 19 | 0.050 |
Why?
|
| Glucuronidase | 1 | 2002 | 8 | 0.050 |
Why?
|
| Esophagectomy | 1 | 2002 | 18 | 0.050 |
Why?
|
| Carcinoma | 1 | 2002 | 63 | 0.050 |
Why?
|
| Esophageal Neoplasms | 1 | 2002 | 49 | 0.050 |
Why?
|
| Transplant Recipients | 1 | 2021 | 20 | 0.050 |
Why?
|
| Pancreas | 1 | 2021 | 29 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 132 | 0.050 |
Why?
|
| Risk Factors | 2 | 2022 | 2224 | 0.040 |
Why?
|
| Cost Savings | 1 | 2020 | 36 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 124 | 0.040 |
Why?
|
| Kidney | 1 | 2021 | 155 | 0.040 |
Why?
|
| Incidence | 1 | 2021 | 731 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2020 | 827 | 0.040 |
Why?
|
| Insulin | 2 | 2008 | 83 | 0.040 |
Why?
|
| Infant | 2 | 2008 | 529 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2009 | 4459 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2009 | 1689 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2009 | 403 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 146 | 0.030 |
Why?
|
| Young Adult | 2 | 2009 | 1855 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2014 | 329 | 0.030 |
Why?
|
| Probability | 2 | 2002 | 71 | 0.020 |
Why?
|
| Reoperation | 2 | 2008 | 818 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2013 | 447 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2002 | 315 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 1077 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2009 | 30 | 0.020 |
Why?
|
| Prognosis | 2 | 2002 | 739 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2009 | 13 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2009 | 61 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2009 | 45 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 163 | 0.020 |
Why?
|
| Raffinose | 1 | 2008 | 1 | 0.020 |
Why?
|
| Procaine | 1 | 2008 | 2 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2008 | 5 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2009 | 46 | 0.020 |
Why?
|
| Amylases | 1 | 2008 | 5 | 0.020 |
Why?
|
| Glutathione | 1 | 2008 | 18 | 0.020 |
Why?
|
| Mannitol | 1 | 2008 | 12 | 0.020 |
Why?
|
| Allopurinol | 1 | 2008 | 5 | 0.020 |
Why?
|
| Lipase | 1 | 2008 | 5 | 0.020 |
Why?
|
| Adenosine | 1 | 2008 | 8 | 0.020 |
Why?
|
| Indiana | 1 | 2008 | 14 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2008 | 25 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2009 | 104 | 0.020 |
Why?
|
| Rituximab | 1 | 2008 | 45 | 0.020 |
Why?
|
| Glucose | 1 | 2008 | 50 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 35 | 0.020 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2008 | 1 | 0.020 |
Why?
|
| Fallopian Tubes | 1 | 2008 | 5 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2009 | 248 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2008 | 25 | 0.020 |
Why?
|
| Biopsy | 1 | 2008 | 199 | 0.020 |
Why?
|
| Cadaver | 1 | 2009 | 349 | 0.020 |
Why?
|
| Ureter | 1 | 2008 | 26 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 185 | 0.020 |
Why?
|
| Endoscopy | 1 | 2008 | 168 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2009 | 618 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 913 | 0.020 |
Why?
|
| Pancreatitis | 1 | 2002 | 20 | 0.010 |
Why?
|
| Medical Records | 1 | 2002 | 31 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2002 | 17 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 43 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2002 | 36 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2002 | 85 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2002 | 75 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2002 | 256 | 0.010 |
Why?
|
| Gene Expression | 1 | 2002 | 182 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 299 | 0.010 |
Why?
|
| Survival Rate | 1 | 2002 | 308 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 443 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 472 | 0.010 |
Why?
|